Coldpack™ to Preview New Pharmaceutical Pouch at PACK EXPO
* Reuters is not responsible for the content in this press release.
New, Sustainable Solution Maintains the Cold Supply Chain for Small Temperature-Controlled Pharmaceutical Items LAS VEGAS--(Business Wire)-- Coldpack™, an innovative insulated packaging solutions leader, today announced it will preview the company`s latest environmentally friendly product, the Pharmaceutical Pouch, at the packaging industry`s largest tradeshow, PACK EXPO. The pouch, a high-performance inflatable thermal envelope, uses Coldpack`s award-winning AirLiner® technology to ensure that sensitive pharmaceutical shipments remain within the necessary temperature range of +2°C to +8°C during the transportation period. Coldpack`s Pharmaceutical Pouch and the company`s other innovative products, including the AntiFreeze VaccineBackpack, will be on display at PACK EXPO, Oct. 5-7, 2009, in Las Vegas, at booth S5573. "With Coldpack`s new Pharmaceutical Pouch, vaccine and biological materials shippers can trust that their valuable cargo will arrive protected and on temperature," said Etienne P. Snollaerts, CEO of Coldpack. "This enhanced product offering is an extension of our commitment to consistently deliver sustainable thermal insulated packaging solutions. The Pharmaceutical Pouch is the first of many new products Coldpack plans to debut in the coming year." The Pharmaceutical Pouch utilizes Coldpack`s signature packaging solution AirLiner, an insulating inflatable film that is manufactured using patented technology. It represents the company`s environmental charter to offer sustainable packaging by developing products that use 50 percent less raw materials and occupy 80 percent less bulk waste than the alternative Styrofoam; offer reduced freight weight and shipping costs; and are manufactured in a zero-waste facility. The Pharmaceutical Pouch will leverage the company`s long-standing partnership with DuPont. Coldpack`s AirLiner uses DuPont`s packaging resins for its patented internal heat-barrier technology to provide high-level thermal performance. Coldpack is conducting numerous testing processes in Europe to bring the commercialized product to the North American market. The unique, reusable pouch is ideal for transferring medication to patients; hospital distributions and supply chains; pharmaceutical wholesale distributions; and the shipment of biological samples or other materials. For more information, visit www.coldpack.com. About Coldpack: Coldpack™ is an innovative insulated packaging company, which provides cold chain solutions for the shipping of temperature-sensitive products worldwide. Its primary product, AirLiner®, is a revolutionary inflatable, insulating liner that easily converts a corrugated box into a cooler. A smarter packaging solution than traditional foam products, AirLiner enables shippers of expedited perishables to protect the temperature, improving the presentation and extending the quality of their brands-all while reducing supply chain costs as well as the carbon footprint of businesses that choose the product. The technology, which was developed under a U.S. Department of Energy grant at a U.C. Lawrence Berkeley lab, has won numerous industry awards including the Flexible Packaging Association`s (FPA) Achievement Award, and the FPA Innovation Showcase`s Highest Achievement Award, Technical Innovation Gold Award and Environmental Achievement Gold Award.Coldpackis ISO 9001:2008 certified by the International Organization for Standardization (ISO) and the International Safe Transit Association (ISTA). Originally founded in 2000, Coldpack`s United States operations are now located in a 25,000-square foot manufacturing facility in San Diego, Calif., with European offices in Paris, France. For more information, visit www.coldpack.com. for Coldpack Christine Welch, 714-573-0899 ext. 225 christine@echomediapr.com Copyright Business Wire 2009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters